欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
FR/V/0135/004
药品名称
Milbemax tablets for Cats
活性成分
milbemycin A<3>-oxim 16.0 mg
praziquantel 40.0 mg
剂型
Tablet
上市许可持有人
Novartis A.H.
参考成员国 - 产品名称
France (FR)
互认成员国 - 产品名称
Germany (DE)
Denmark (DK)
Milbemax Vet. (katte)
Belgium (BE)
Milbemax filmomhulde tabletten voor katten
Netherlands (NL)
Luxembourg (LU)
United Kingdom (Northern Ireland) (XI)
Ireland (IE)
Austria (AT)
Milbemax - Tabletten fuer Katzen ab 2 kg
Spain (ES)
Portugal (PT)
Italy (IT)
Sweden (SE)
Norway (NO)
Finland (FI)
Greece (GR)
Poland (PL)
Hungary (HU)
Cyprus (CY)
Czechia (CZ)
Slovakia (SK)
Slovenia (SI)
MILBEMAX tablete za mačke
许可日期
2003/04/17
最近更新日期
2023/09/20
药物ATC编码
QP54AB51 milbemycin oxime, combinations
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
Full Dossier (art.5)
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final SPC
|
Final SmPC _ Milbemax cat
Date of last change:2024/09/06
Final Product Information
|
Milbemax_fcTablets_Cat_en_MRP_QRD_clean_Final
Date of last change:2024/09/06
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase